
Medpace Holdings, Inc.
Nasdaq · Services-Commercial Physical & Biological Research
Company Overview
A concise company profile alongside the latest public filing activity.
Medpace Holdings is a clinical research organization that provides outsourced clinical development services—including trial design, management, and regulatory support—to pharmaceutical, biotechnology, and medical device companies.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Troendle August J.President & CEO | Sell | $8.74M | 13,995at $624.45 | Aug 21, 2026 |
| Troendle August J.President & CEO | Sell | $1.23M | 1,983at $620.23 | Aug 24, 2026 |
| Brady Kevin M.CFO & Treasurer | Sell | $2.13M | 3,400at $625.24 | Aug 20, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable MEDP activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.